Biopharmaceutical research and development is uncovering new insights into how we view, understand and treat cancer, helping to transform a terrifying diagnosis into a healthier and longer life for patients.
Thanks to investments in cancer research, the survival rates are increasing dramatically for many forms of the disease. Since 1975, 5-year survival rates went up 21% for breast cancer; 50% for prostate cancer; 36% for colon cancer and 54% for lung cancer.
These powerful statistics help illustrate how biopharmaceutical innovations are enabling us to gradually win our war with this dreaded disease:
- Cancer patients lived a combined 23 million years longer between 1988 and 2000, thanks to investments in cancer research
- Cancer death rates have decreased 22% since 1991
- Today, 83% of children with cancer survive compared to 58% in 1970
- More than 80% of people with chronic myeloid leukemia (CML) experience 10-year survival rates compared to 20% a decade ago
- Currently, there are more than 350 cancer medicines and vaccines in development based on biological processes
The path to creating life-extending and even life-saving treatments is an extremely long, labor-intensive effort that involves major investment. Each new cancer treatment, whether it extends life by six months or cures the disease, reflects how innovation leads to improved patient outcomes. Patients benefit. Society benefits. The odds are that someday you, or someone you love, will benefit.